Justin B. Klee
Director, Co-Chief Executive Officer · 4 filings · Latest: Mar 5, 2026
Amylyx Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
AMLX | Justin B. Klee | Director, Co-Chief Executive Officer | Mar 2, 2026 | Sale | $14.47 | 29,282 | $423.8K | 3,334,616 | |
AMLX | Klee Justin B. | — | Mar 2, 2026 | Proposed Sale | $14.47 | 29,282 | $423.8K | — | |
AMLX | Justin B. Klee | Director, Co-Chief Executive Officer | Feb 2, 2026 | Sale | $14.69 | 15,500 | $227.6K | 3,363,898 | |
AMLX | Klee Justin B. | — | Feb 2, 2026 | Proposed Sale | $14.68 | 15,500 | $227.6K | — | |
AMLX | Justin B. Klee | Director, Co-Chief Executive Officer | Jan 16, 2026 | Sale | $13.89 | 1,995 | $27.7K | 3,379,398 | |
AMLX | Justin B. Klee | Director, Co-Chief Executive Officer | Jan 16, 2026 | Option Exercise | $7.57 | 2,847 | $21.6K | 3,381,393 | |
AMLX | Justin B. Klee | Director, Co-Chief Executive Officer | Jan 15, 2026 | Sale | $13.58 | 136,193 | $1.8M | 3,378,546 | |
AMLX | Justin B. Klee | Director, Co-Chief Executive Officer | Jan 15, 2026 | Option Exercise | $7.57 | 197,153 | $1.5M | 3,514,739 | |
AMLX | JUSTIN KLEE | — | Jan 16, 2026 | Proposed Sale | $13.52 | 1,995 | $27.0K | — | |
AMLX | JUSTIN KLEE | — | Jan 15, 2026 | Proposed Sale | $14.07 | 136,193 | $1.9M | — | |
AMLX | Klee Justin B. | — | Jan 6, 2026 | Proposed Sale | $11.09 | 7,715 | $85.6K | — |